Suppr超能文献

[腹腔镜治疗卵巢交界性肿瘤:54例患者分析及临床结果]

[Laparoscopic treatment of borderline ovarian tumor: analysis of 54 patients and clinical outcomes].

作者信息

Camatte S, Deffieux X, Castaigne D, Thoury A, Fourchotte V, Pautier P, Lhommé C, Duvillard P, Morice P

机构信息

Service de chirurgie, institut Gustave-Roussy, Villejuif, France.

出版信息

Gynecol Obstet Fertil. 2005 Jun;33(6):395-402. doi: 10.1016/j.gyobfe.2005.04.022.

Abstract

OBJECTIVE

The aim of this study is to assess the clinical outcomes of laparoscopic treatment of borderline ovarian tumor (BOT).

PATIENTS AND METHODS

Retrospective analysis of 54 patients treated using a laparoscopic approach for a BOT between January 1984 and January 2002.

RESULTS

A conservative management was initially performed in 45 patients (83%). Twenty-six patients underwent a reassessment surgery and 7 (27%) of them were upstaged following this procedure. Seven (13%) patients recurred in a remaining ovary following conservative surgery (5 patients) or on the peritoneum (2 patients). Three port-site localizations were observed. None of the patients treated with conservative management had recurrent disease under the form of ovarian carcinoma. Nine spontaneous pregnancies were observed in 6 patients from a group of 19 patients desiring pregnancy. All patients are today alive and disease-free.

DISCUSSION AND CONCLUSION

Our study suggests that laparoscopic treatment could be safely performed in young patients with early stage BOT. Such procedure should be further evaluated in patients with BOT and peritoneal implants.

摘要

目的

本研究旨在评估腹腔镜治疗卵巢交界性肿瘤(BOT)的临床效果。

患者与方法

回顾性分析1984年1月至2002年1月间采用腹腔镜方法治疗BOT的54例患者。

结果

最初对45例患者(83%)实施了保守治疗。26例患者接受了再次评估手术,其中7例(27%)在此手术后分期升高。7例(13%)患者在保守手术后于对侧卵巢(5例患者)或腹膜(2例患者)复发。观察到3例端口部位复发。接受保守治疗的患者中无一例以卵巢癌形式出现复发性疾病。在一组19例有妊娠意愿的患者中,6例患者出现了9次自然妊娠。目前所有患者均存活且无疾病。

讨论与结论

我们的研究表明,腹腔镜治疗对于早期BOT的年轻患者可安全实施。对于伴有腹膜种植的BOT患者,该手术应进一步评估。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验